The global patient engagement solutions market size is expected to reach around US$ 8 billion by 2030 from US$ 23.38 billion in 2022 and is expected to grow at an impressive double-digit rate of 20.3% from 2022 to 2030.
The study includes drivers and restraints of this market. The study provides an analysis of the global patient engagement solutions market for the period 2017-2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.
The patient engagement solutions include a variety of services as well as accompanying healthcare information technology and hardware. These services are used to get patients involved in their own health. These platforms employ a patient-centered healthcare delivery system to improve health outcomes and ensure value-based care, which is expected to boost the growth of the global patient engagement solutions market during the forecast period.
The adoption of government regulations and initiatives to patient-centric care as well as an increase in demand for patient engagement solutions and the use of mobile health applications are driving the expansion of the global patient engagement solutions over the projection period. The patient engagement solutions have become increasingly popular as the global burden of chronic diseases and the geriatric population has grown.
Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1579
Market Estimations Y-O-Y:
- Market Size Was Valued In 2021: US$ 19.46 Billion
- Market Size Is Projected to Grow By 2022: US$ 23.38 Billion
- Market Size Is Projected to Grow By 2023: US$ 28.09 Billion
- Market Size Is Projected to Grow By 2024: US$ 33.77 Billion
- Market Size Is Projected to Grow By 2025: US$ 40.6 Billion
- Market Size Is Projected to Grow By 2026: US$ 48.83 Billion
- Market Size Is Projected to Grow By 2027: US$ 58.75 Billion
- Market Size Is Projected to Grow By 2028: US$ 70.7 Billion
- Market Size Is Projected to Grow By 2029: US$ 85.1 Billion
- Market Size Is Projected to Grow By 2030: US$ 102.46 Billion
- Compound Annual Growth Rate (CAGR) from 2022 to 2030: 20.3 percent
Market Dynamics
Drivers
Growing importance of health tracking software
The health tracking is becoming more common as the prevalence of health issues rises. The patients in today’s technologically advanced world have access to information that can help them receive individualized care and keep track of their health. People are increasingly keeping track of their health data and many of them share it with their health and fitness coaches and doctors in order to keep track of their health. The health and fitness tracking devices, which are in great demand, are also helping to drive the growth of patient engagement solutions market during the forecast period.
Restraints
High cost of patient engagement solutions deployment
The healthcare information technology systems are expensive software solutions. Furthermore, the cost of software updates and operating costs may exceed the cost of the product. The maintenance and support services which include software upgradation and modification are a recurrent cost that accounts for more than half of the total cost of ownership. Due to a lack of internal information technology experience in the healthcare industry, end users must be trained in order to maximize the productivity of various healthcare information technology solutions, which increases the system’s cost. Thus, the high cost of patient engagement solutions is hindering the growth of the market.
Opportunities
Technological advancements
The patients can share information through technology to help with personalized care and health monitoring for those with chronic care and health monitoring for those with chronic illnesses. The number of patients who track their health data has risen and many are prepared to disclose information in order to keep track of their health. The incorporation of technologies such as patient engagement technology, artificial intelligence (AI), the internet of things, health information technology solutions are expected to result in the development of patient engagement solutions features and capabilities. As a result, the technological advancements is creating lucrative opportunities for the growth of the patient engagement solutions market during the forecast period.
Related Report
- Behavioral Health Market Research Report 2022 to 2030
- Digital Patient Monitoring Devices Market Research Report 2022 – 2030
- Remote Patient Monitoring Systems Market Research Report 2022 - 2030
Challenges
Lack of data security
The problems about the security of patient health data are obstructing the transfer of the information among healthcare practitioners. As a result, patient engagement initiatives in various healthcare organizations are being hampered and the adoption of patient engagement solutions among prospective end users is being limited. Thus, the lack of data security is a major challenge for the growth of the patient engagement solutions market over the projection period.
Report Highlights
- Based on the delivery type, the web/cloud-based segment dominated the global patient engagement solutions market in 2020 with highest market share. The cloud-based solutions enable healthcare businesses to communicate and integrate data in real time from several locations or systems.
- Based on the end use, providers segment is estimated to be the most opportunistic segment during the forecast period. To control rising healthcare costs, enhance financial results, and provide value-based treatment, providers are increasingly turning to patient engagement technologies.
- Based on the therapeutic area, chronic diseases segment is estimated to be the most opportunistic segment during the forecast period. The significant burden of chronic diseases and the need to effectively manage these ailments while lowering total healthcare expenditures is driving the segment growth.
Regional Snapshot
North America is the largest segment for patient engagement solutions market in terms of region. This is attributed due to an increase in the quantity of high-quality healthcare services as well as increased legislative reforms and new incentive-based payment mechanisms.
Asia-Pacific region is the fastest growing region in the patient engagement solutions market. The patient engagement solutions market opportunities in Asia-Pacific region are being created by factors such as rising healthcare spending, increased awareness of mobile health, and favorable regulatory frameworks.
Why should you invest in this report?
If you are aiming to enter the global patient engagement solutions market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for patient engagement solutions are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global patient engagement solutions market include:
Some of the prominent players in the global patient engagement solutions market include:
- McKesson Corporation
- Allscripts Healthcare Solutions
- Orion Health Ltd.
- GetWellNetwork Inc.
- Cerner Corporation
- Medecision Inc.
- Phytel Inc.
- Athenahealth Inc.
- YourCareUniverse Inc.
- Lincor Solutions Ltd.
Segments Covered in the Report
By Delivery Type
- Web-based/Cloud-based
- On-premise
By Component
- Software
- Standalone
- Integrated
- Services
- Consulting
- Implementation & Training
- Support & Maintenance
- Others
- Hardware
By End Use
- Payers
- Providers
- Individual Users
By Application
- Social Management
- Health Management
- Home Healthcare Management
- Financial Health Management
By Therapeutic Area
- Chronic Diseases
- Fitness
- Women’s Health
- Mental Health
- Others
By Functionality
- Communication
- Health Tracking & Insights
- Billing & Payments
- Administrative
- Patient Education
- Others
Regional Analysis:
The geographical analysis of the global patient engagement solutions market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global patient engagement solutions Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global patient engagement solutions market in 2030?
- What is the expected CAGR for the patient engagement solutions market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global patient engagement solutions market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Functionality Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Patient Engagement Solutions Market
5.1. COVID-19 Landscape: Patient Engagement Solutions Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Patient Engagement Solutions Market, By Delivery Type
8.1. Patient Engagement Solutions Market, by Delivery Type, 2022-2030
8.1.1. Web-based/Cloud-based
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. On-premise
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Patient Engagement Solutions Market, By Component
9.1. Patient Engagement Solutions Market, by Component Type, 2022-2030
9.1.1. Software
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Services
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Hardware
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Patient Engagement Solutions Market, By End Use
10.1. Patient Engagement Solutions Market, by End Use Type, 2022-2030
10.1.1. Payers
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Providers
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Individual Users
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Patient Engagement Solutions Market, By Application
11.1. Patient Engagement Solutions Market, by Application Type, 2022-2030
11.1.1. Social Management
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Health Management
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Home Healthcare Management
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Financial Health Management
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Patient Engagement Solutions Market, By Therapeutic Area
12.1. Patient Engagement Solutions Market, by Therapeutic Area, 2022-2030
12.1.1. Chronic Diseases
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Fitness
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Women’s Health
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. Mental Health
12.1.4.1. Market Revenue and Forecast (2017-2030)
12.1.5. Others
12.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Patient Engagement Solutions Market, By Functionality
13.1. Patient Engagement Solutions Market, by Component Type, 2022-2030
13.1.1. Communication
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Health Tracking & Insights
13.1.2.1. Market Revenue and Forecast (2017-2030)
13.1.3. Billing & Payments
13.1.3.1. Market Revenue and Forecast (2017-2030)
13.1.4. Administrative
13.1.4.1. Market Revenue and Forecast (2017-2030)
13.1.5. Patient Education
13.1.5.1. Market Revenue and Forecast (2017-2030)
13.1.6. Others
13.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Patient Engagement Solutions Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.1.2. Market Revenue and Forecast, by Component (2017-2030)
14.1.3. Market Revenue and Forecast, by End Use (2017-2030)
14.1.4. Market Revenue and Forecast, by Application (2017-2030)
14.1.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.1.6. Market Revenue and Forecast, by Functionality (2017-2030)
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.1.7.2. Market Revenue and Forecast, by Component (2017-2030)
14.1.7.3. Market Revenue and Forecast, by End Use (2017-2030)
14.1.7.4. Market Revenue and Forecast, by Application (2017-2030)
14.1.8. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.1.8.1. Market Revenue and Forecast, by Functionality (2017-2030)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.1.9.2. Market Revenue and Forecast, by Component (2017-2030)
14.1.9.3. Market Revenue and Forecast, by End Use (2017-2030)
14.1.9.4. Market Revenue and Forecast, by Application (2017-2030)
14.1.10. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.1.11. Market Revenue and Forecast, by Functionality (2017-2030)
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.2.2. Market Revenue and Forecast, by Component (2017-2030)
14.2.3. Market Revenue and Forecast, by End Use (2017-2030)
14.2.4. Market Revenue and Forecast, by Application (2017-2030)
14.2.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.2.6. Market Revenue and Forecast, by Functionality (2017-2030)
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.2.8.2. Market Revenue and Forecast, by Component (2017-2030)
14.2.8.3. Market Revenue and Forecast, by End Use (2017-2030)
14.2.9. Market Revenue and Forecast, by Application (2017-2030)
14.2.10. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.2.10.1. Market Revenue and Forecast, by Functionality (2017-2030)
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.2.11.2. Market Revenue and Forecast, by Component (2017-2030)
14.2.11.3. Market Revenue and Forecast, by End Use (2017-2030)
14.2.12. Market Revenue and Forecast, by Application (2017-2030)
14.2.13. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.2.14. Market Revenue and Forecast, by Functionality (2017-2030)
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.2.15.2. Market Revenue and Forecast, by Component (2017-2030)
14.2.15.3. Market Revenue and Forecast, by End Use (2017-2030)
14.2.15.4. Market Revenue and Forecast, by Application (2017-2030)
14.2.16. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.2.16.1. Market Revenue and Forecast, by Functionality (2017-2030)
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.2.17.2. Market Revenue and Forecast, by Component (2017-2030)
14.2.17.3. Market Revenue and Forecast, by End Use (2017-2030)
14.2.17.4. Market Revenue and Forecast, by Application (2017-2030)
14.2.18. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.2.18.1. Market Revenue and Forecast, by Functionality (2017-2030)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.3.2. Market Revenue and Forecast, by Component (2017-2030)
14.3.3. Market Revenue and Forecast, by End Use (2017-2030)
14.3.4. Market Revenue and Forecast, by Application (2017-2030)
14.3.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.3.6. Market Revenue and Forecast, by Functionality (2017-2030)
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.3.7.2. Market Revenue and Forecast, by Component (2017-2030)
14.3.7.3. Market Revenue and Forecast, by End Use (2017-2030)
14.3.7.4. Market Revenue and Forecast, by Application (2017-2030)
14.3.8. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.3.9. Market Revenue and Forecast, by Functionality (2017-2030)
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.3.10.2. Market Revenue and Forecast, by Component (2017-2030)
14.3.10.3. Market Revenue and Forecast, by End Use (2017-2030)
14.3.10.4. Market Revenue and Forecast, by Application (2017-2030)
14.3.11. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.3.11.1. Market Revenue and Forecast, by Functionality (2017-2030)
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.3.12.2. Market Revenue and Forecast, by Component (2017-2030)
14.3.12.3. Market Revenue and Forecast, by End Use (2017-2030)
14.3.12.4. Market Revenue and Forecast, by Application (2017-2030)
14.3.12.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.3.12.6. Market Revenue and Forecast, by Functionality (2017-2030)
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.3.13.2. Market Revenue and Forecast, by Component (2017-2030)
14.3.13.3. Market Revenue and Forecast, by End Use (2017-2030)
14.3.13.4. Market Revenue and Forecast, by Application (2017-2030)
14.3.13.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.3.13.6. Market Revenue and Forecast, by Functionality (2017-2030)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.4.2. Market Revenue and Forecast, by Component (2017-2030)
14.4.3. Market Revenue and Forecast, by End Use (2017-2030)
14.4.4. Market Revenue and Forecast, by Application (2017-2030)
14.4.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.4.6. Market Revenue and Forecast, by Functionality (2017-2030)
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.4.7.2. Market Revenue and Forecast, by Component (2017-2030)
14.4.7.3. Market Revenue and Forecast, by End Use (2017-2030)
14.4.7.4. Market Revenue and Forecast, by Application (2017-2030)
14.4.8. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.4.9. Market Revenue and Forecast, by Functionality (2017-2030)
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.4.10.2. Market Revenue and Forecast, by Component (2017-2030)
14.4.10.3. Market Revenue and Forecast, by End Use (2017-2030)
14.4.10.4. Market Revenue and Forecast, by Application (2017-2030)
14.4.11. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.4.12. Market Revenue and Forecast, by Functionality (2017-2030)
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.4.13.2. Market Revenue and Forecast, by Component (2017-2030)
14.4.13.3. Market Revenue and Forecast, by End Use (2017-2030)
14.4.13.4. Market Revenue and Forecast, by Application (2017-2030)
14.4.13.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.4.13.6. Market Revenue and Forecast, by Functionality (2017-2030)
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.4.14.2. Market Revenue and Forecast, by Component (2017-2030)
14.4.14.3. Market Revenue and Forecast, by End Use (2017-2030)
14.4.14.4. Market Revenue and Forecast, by Application (2017-2030)
14.4.14.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.4.14.6. Market Revenue and Forecast, by Functionality (2017-2030)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.5.2. Market Revenue and Forecast, by Component (2017-2030)
14.5.3. Market Revenue and Forecast, by End Use (2017-2030)
14.5.4. Market Revenue and Forecast, by Application (2017-2030)
14.5.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.5.6. Market Revenue and Forecast, by Functionality (2017-2030)
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.5.7.2. Market Revenue and Forecast, by Component (2017-2030)
14.5.7.3. Market Revenue and Forecast, by End Use (2017-2030)
14.5.7.4. Market Revenue and Forecast, by Application (2017-2030)
14.5.8. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.5.8.1. Market Revenue and Forecast, by Functionality (2017-2030)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Delivery (2017-2030)
14.5.9.2. Market Revenue and Forecast, by Component (2017-2030)
14.5.9.3. Market Revenue and Forecast, by End Use (2017-2030)
14.5.9.4. Market Revenue and Forecast, by Application (2017-2030)
14.5.9.5. Market Revenue and Forecast, by Therapeutic Area (2017-2030)
14.5.9.6. Market Revenue and Forecast, by Functionality (2017-2030)
Chapter 15. Company Profiles
15.1. McKesson Corporation
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Allscripts Healthcare Solutions
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Orion Health Ltd.
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. GetWellNetwork Inc.
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Cerner Corporation
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Medecision Inc.
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Phytel Inc.
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Athenahealth Inc.
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. YourCareUniverse Inc.
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Lincor Solutions Ltd.
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1579
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
0 Comments